AZ-UNIVERSAL-ELECTRONICS
Universal Electronics Inc. (NASDAQ: UEIC), the worldwide leader in universal control technology for entertainment and smart home devices today announced that it has been named a CES® 2023 Innovation Awards Honoree for its UEI Eterna remote control. This year’s CES Innovation Awards program received a record-high number of over 2100 submissions. The announcement was made ahead of CES 2023, the world’s most influential technology event, happening Jan. 5-8 in Las Vegas, NV.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221222005096/en/
UEI's Eterna Remote Receives the CES 2023 Innovation Award (Graphic: Business Wire)
Maximum performance with minimum battery waste
Targeting TV service providers that want to minimize their carbon footprint and battery waste without compromising on the consumer experience, UEI has designed and developed its most advanced and sustainable voice remote-control platform ever.
The UEI Eterna family of products are built with UEI’s new Xtreme Low-Power Bluetooth LE silicon making them 2.5 times more powerful and up to 10 times more efficient than the previous generation of voice remote controls. In combination with a revolutionary high-density photovoltaic panel that harvests three times more energy than traditional panels, it can self-power despite intense usage or in low light conditions.
For better accessibility in the dark, the UEI Eterna line supports Ambient-Aware backlighting. The backlight activates when there is insufficient lighting in the room. This further reduces power consumption to a bare minimum. UEI Eterna is built with recycled and recyclable materials and packaged free of single-use plastics (SUP). To facilitate refurbishment and recycling programs, the products are specifically designed for easy disassembly which helps to minimize waste and maximize the re-use of field returned units.
“With sustainability as a driving force for product innovation and design at UEI, we are delighted that our UEI Eterna product received this award,” said Menno Koopmans, SVP of Global Sales and Marketing. “The UEI Eterna remote is the first of its kind that delivers on our customers’ sustainability goals without having to compromise on user experience or product features. This innovation is a clear milestone on our journey towards a battery-less world.”
The UEI Eterna and UEI Eterna XLR also feature a unique Interactive Light Bar that communicates its status in real-time with the end user using distinct and recognizable light patterns.
The product line comes with a unique pre-integrated support system that enhances its sustainability performance as it minimizes customer service calls or related truck rolls:
- Powered by QuickSet® Cloud, it supports UEI’s unique and widely adopted automated discovery and set-up capability to pair the set-top-box remote with the customer’s TV, soundbar or audio system. In 2022 alone, QuickSet is estimated to have saved UEI’s existing pay TV customers over 4 million man-hours of programming time.
- It is supported by UEI’s Virtual Agent that provides self-help capabilities during installation, feature discovery and troubleshooting, and is available on both the TV screen and the mobile device.
- It comes with the turnkey white label My Nevo Companion App to enable the setup and support via a mobile device, customize the user preferences, and optimize power management.
- UEI’s new plug-and-play SDK facilitates easy and trouble-free integration with Android TV set-top boxes.
The UEI Eterna family of products is developed for Android TV and RDK operating systems and is scheduled to be available by the end of the first quarter of 2023.
To schedule a press tour or demo please visit here, or come by our booth #52014 at the Venetian Expo at CES taking place in Las Vegas on January 5-8.
About the CES Innovations Award
The CES Innovation Awards program is an annual competition honoring outstanding design and engineering in 28 consumer technology product categories. Those with the highest rating receive the “Best of Innovation” distinction. An elite panel of industry expert judges, including members of the media, designers, engineers and more, reviewed submissions based on innovation, engineering and functionality, aesthetics and design.
About Universal Electronics
Universal Electronics Inc. (NASDAQ:UEIC), Universal Electronics Inc. (NASDAQ: UEIC), the global leader in wireless universal control solutions for home entertainment and smart home devices; designs, develops, manufactures, ships and supports hardware and software control and sensor technology solutions. UEI partners with many Fortune 500 customers, including Comcast, Vivint Smart Home, Samsung, LG, Sony, and Daikin to serve video, telecommunications, security service providers, television, smart home, and HVAC system manufacturers. For over 35 years, UEI has been pioneering breakthrough innovations such as voice control and QuickSet cloud, the world’s leading platform for automated set-up and control of devices in the home. For more information visit www.uei.com
Safe Harbor Statement
This press release contains forward-looking statements that are made pursuant to the Safe-Harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting something other than historical fact are intended to identify forward-looking statements. These forward-looking statements involve a number of risks and uncertainties, including the timely development, delivery, technical performance, and market acceptance of products and technologies identified in this release; the purchasing by UEI customers of the UEI ETERNA products identified in this release in the quantities anticipated by management; the adoption of the energy harvesting and low power technologies identified in this release by UEI customers, the continued penetration and growth of UEI low power, energy harvesting, and other products and consumer technologies identified in this release; and other factors described in UEI’s filings with the Securities and Exchange Commission. The actual results that UEI achieves may differ materially from any forward-looking statement due to such risks and uncertainties. UEI undertakes no obligations to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221222005096/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aspect Announces CEO Leadership Transition and New Independent Board7.1.2026 00:13:00 CET | Press release
Aspect, a leading provider of cloud-based workforce management solutions, has announced a leadership transition, including the appointment of Jeff Kupietzky as Interim Chief Executive Officer and the formation of a new independent Board of Directors, marking an important next chapter for the company. As part of this transition, Darryl Kelly will step down as Chief Executive Officer and transition into a Strategic Advisor role, effective January 1, 2026. Darryl led Aspect through a pivotal period of transformation, helping reposition the business, refine its vision, and reinvigorate its innovation and execution. The company and its stakeholders thank Darryl for his leadership and contributions during a period of meaningful change. With Darryl continuing as Strategic Advisor, the organization retains continuity for employees, customers, and stakeholders. “Aspect is starting a new season, building upon the strong foundation we’ve created together,” said Darryl Kelly. “This transition is a
Brenus Pharma Reports Favorable Tolerability and Clinical Signals in Early Preliminary Results of First-In-Human Study for STC-1010 in Unresectable Metastatic Stage Colorectal Cancer (MSS CRC) Patients6.1.2026 21:00:00 CET | Press release
Brenus Pharma, a clinical stage biotechnology company unlocking the immune system in vivo to fight solid tumors, announced the successful completion of the first dose levels in its ongoing first-in-human study. The multi-center, open-label trial (NCT06934538) is a phase Ia/Ib study designed to evaluate safety, tolerability and preliminary clinical activity of STC-10101 in a first line setting. It will include in vivo analysis of immune and tumor dynamics during dose escalation of treatment and cohort extension to patients with unresectable locally advanced (stage IIIC, T4b) or unresectable metastatic (stage IV) MSS2 colorectal cancer (CRC). Early findings indicate that the first dose levels have been successfully completed with good overall tolerance and no-dose-limiting toxicities observed to date. “We are pleased to report that the safety profile observed to date is good and consistent with our expectations with no DLT,” said Paul Bravetti, CEO of Brenus Pharma. “Moreover, preliminar
SPIE, the International Society for Optics and Photonics, Announces Its 2026 Fellows6.1.2026 20:35:00 CET | Press release
The Society is welcoming 40 new Fellow Members from across the globe SPIE, the international society for optics and photonics, welcomes 40 Members as new Fellows of the Society in the 2026 cohort. They join their Fellow Member colleagues in being honored for their excellent technical achievements, as well as for their substantial service to the optics and photonics community and to SPIE. Fellows are Members of the Society who have made significant scientific and technical contributions in the multidisciplinary fields of optics, photonics, and imaging. Since the Society's inception in 1955, more than 1,800 SPIE Members have become Fellows. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260106630672/en/ SPIE, the international society for optics and photonics, announces its 2026 Fellows This year’s inductees are high-profile leaders in academia, industry, and government, many of whom are particularly prominent in their support
Chemelex Adds Electric Heat Trace Group Ltd.’s SmartTrace Monitoring Platform to its Heat Tracing Portfolio6.1.2026 20:00:00 CET | Press release
Chemelex, a global leader in electric thermal and sensing solutions, today announced the successful completion of its acquisition of substantially all the assets and ongoing operations of Electric Heat Trace Group Ltd. (EHT Group), headquartered in Ontario, Canada. This strategic move marks an exciting start to the new year and reinforces Chemelex’s commitment to delivering smarter, data-driven solutions for industrial heat trace systems. EHT Group is a recognized innovator in heat trace management, offering advanced software, integrated controller solutions, wireless communication modules, and comprehensive field services. Its flagship platform, SmartTrace, is a robust solution available in both cloud-based and on-premises deployments that enables predictive maintenance, minimizes downtime, and provides secure remote monitoring—helping customers achieve greater reliability and operational efficiency. This endeavor will help Chemelex support greater operational efficiencies for our cus
ZIIHERA Plus TEVIMBRA and Chemotherapy: A Potential New Standard for First-Line HER2+ Advanced GEA6.1.2026 19:30:00 CET | Press release
Combination therapy showed compelling survival and disease control compared to current standard, regardless of PD-L1 statusHigh GEA burden in Asia, where BeOne holds ZIIHERA rights, signals potential broad patient impactResults to be presented as a Late-Breaking Abstract Oral Presentation at ASCO GI on January 8, 2026 BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced full results from the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), a HER2-targeted bispecific antibody, in combination with chemotherapy, with and without PD-1 inhibitor TEVIMBRA® (tislelizumab), as a first-line treatment for HER2-positive (HER2+) locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). These data, including the first interim overall survival (OS) analysis, will be presented as a Late-Breaking Abstract Oral Presentation (#LBA285) at the American Society of Clinical Oncology Gastrointestinal Cancers Symposium (ASCO GI) on
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom